Amedica Corp. (AMDA) Now Covered by Maxim Group
Stock analysts at Maxim Group started coverage on shares of Amedica Corp. (NASDAQ:AMDA) in a research note issued to investors on Thursday. The firm set a “buy” rating and a $5.00 price target on the stock.
Shares of Amedica Corp. (NASDAQ:AMDA) opened at 0.7511 on Thursday. The firm’s 50-day moving average price is $0.80 and its 200 day moving average price is $1.03. Amedica Corp. has a 12 month low of $0.60 and a 12 month high of $3.62. The company’s market cap is $17.71 million.
Amedica Corp. Company Profile
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.
Receive News & Stock Ratings for Amedica Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica Corp. and related stocks with our FREE daily email newsletter.